Health valuation connects claim estimates with earnings, capital, regulation, and the movement of health care funds. This guide develops those connections through twenty original written exercises and sixty technical lessons, including health RBC calculations, Medicare financing, Medicaid capitation, and Canadian funding. It follows the supplied November 2026/March 2027/July 2027 syllabus allocation for the upcoming November administration as of October 16, 2026. The exercises are educational constructed-response practice: the supplied evidence does not establish the official response format. Source s3 supports syllabus relevance, while worked examples use stated assumptions and established subject knowledge rather than treating the outline as technical verification.
What this guide covers
Practice health reserving, reporting, U.S. regulation and program financing with 20 tasks and 60 concepts.
Reserving
1. Ultimate Claims, Case Reserves, and Residual IBNR
For a consistent incurred period, ultimate claims equal paid claims plus unpaid claim liabilities. Recorded case reserves estimate obligations on identified claims; the remaining provision may include unreported claims and development on reported claims. Organizations differ in how broadly they use the term IBNR, so reconcile definitions before combining estimates. ASOP 5 addresses incurred health and disability claim estimation. Establish whether expenses, recoveries, and reinsurance are included, and keep those boundaries consistent across paid data, ultimate estimates, and booked liabilities.
Worked example: A medical block has estimated ultimate benefits of $18 million and payments of $14 million. Total unpaid benefits are $4 million. If case reserves already equal $1.1 million, the additional provision is $2.9 million, rather than another $4 million.
Common mistake: Treating case reserves as an addition to an already total unpaid estimate double counts reported obligations and overstates liabilities.
Official syllabus reference: [1]
2. Incurred-by-Paid Development Triangles
A development triangle groups claims by incurred cohort and measures payments at successive development ages. Incremental cells show payments during one lag interval; cumulative cells sum payments through that age. The latest diagonal contains the most recent observation for each cohort, while older cohorts usually have more complete development. Construct triangles on a consistent service-date and payment-date basis. Changes in reversals, capitation, benefit categories, or processing cutoffs can create apparent development patterns that reflect data construction rather than underlying claim emergence.
Worked example: January claims paid $400,000 during January, $250,000 during February, and $100,000 during March. Incremental development is those three amounts; cumulative development is $400,000, $650,000, and $750,000. A March valuation uses January's third cumulative observation alongside younger observations for February and March.
Common mistake: Adding cumulative development cells together counts earlier payments repeatedly and produces a false claim total for the incurred cohort.
Official syllabus reference: [1]
3. Completion Proportions and Development Multipliers
A paid completion proportion is cumulative paid claims divided by estimated ultimate claims at a specified development age. Ultimate claims can therefore be estimated as paid claims divided by that proportion. The reciprocal is the paid-to-ultimate development multiplier. Unpaid claims equal estimated ultimate less paid. Keep percentages and multipliers distinct: 80% completion corresponds to a 1.25 multiplier. This method is most reliable when historical payment timing remains relevant; at early ages, small completion errors can create large changes in estimated ultimate claims.
Worked example: A cohort has paid $3.6 million and is estimated to be 75% complete. Its development multiplier is 1/0.75, or 1.3333. Estimated ultimate claims are $4.8 million, leaving $1.2 million unpaid for the same incurred period.
Common mistake: Multiplying payments by the completion proportion reduces an incomplete amount further instead of estimating the cohort's full ultimate cost.
Official syllabus reference: [1]
4. Dollar-Weighted Link Ratios
An age-to-age link ratio compares cumulative claims at a later development age with claims at the preceding age. A dollar-weighted ratio divides aggregated later-age amounts by aggregated earlier-age amounts for the same eligible cohorts. This differs from averaging individual cohort ratios because large cohorts receive more weight. Multiply selected successive link ratios to obtain a cumulative development factor. Selection still requires judgment about outliers, changing business mix, and calendar-period effects; a mathematically precise weighted ratio can remain biased when its historical cohorts are not representative.
Worked example: Two cohorts develop from $1 million to $1.2 million and from $4 million to $4.4 million. The weighted link ratio is $5.6 million divided by $5 million, or 1.12. The unweighted average of 1.20 and 1.10 is 1.15.
Common mistake: Calling an unweighted mean dollar-weighted conceals a different influence pattern and can materially change factors when cohort sizes differ.
Official syllabus reference: [1]
5. Bornhuetter-Ferguson Estimates for Immature Claims
The Bornhuetter-Ferguson approach estimates unpaid claims as an independently selected expected ultimate amount multiplied by the expected unpaid proportion. Add actual payments to obtain the resulting ultimate estimate. Unlike pure paid development, the unpaid estimate does not scale directly with early paid experience. This can stabilize immature cohorts, but only if the expected ultimate and development pattern are credible. Avoid describing the method as assumption-free: pricing expectations, exposure changes, and an inappropriate payment pattern can all introduce bias, particularly when utilization has shifted.
Worked example: Expected ultimate claims are $8 million, estimated completion is 30%, and actual paid claims are $2.1 million. Bornhuetter-Ferguson unpaid claims are $8 million times 70%, or $5.6 million. Adding payments gives a $7.7 million ultimate estimate.
Common mistake: Applying the unpaid percentage to actual payments substitutes a different calculation and removes the method's independent expected-claims foundation.
Official syllabus reference: [1]
6. Frequency-Severity Claim Estimation
A frequency-severity model separates how many claims or services are expected from their average cost. Expected cost equals exposure multiplied by frequency per exposure unit multiplied by severity per claim or service. This decomposition helps explain utilization changes separately from price or intensity changes. The claim unit must remain stable: admissions, scripts, encounters, and claim lines are not interchangeable. Frequency and severity may also move together, so sensitivity testing should consider dependence rather than assuming every change can be independently extrapolated without affecting the other component.
Worked example: A population has 50,000 member months, expected frequency of 0.04 visits per member month, and average allowed cost of $150 per visit. Expected allowed claims are $300,000. A 10% frequency increase raises that amount to $330,000 if severity stays unchanged.
Common mistake: Combining admission frequency with claim-line severity mixes different service units and can distort costs despite apparently consistent dollar arithmetic.
Official syllabus reference: [1]
7. Processing Acceleration and Calendar-Period Bias
Payment development reflects operational timing as well as underlying claim cost. Faster adjudication raises cumulative payments at a given development age without necessarily changing ultimate claims. Applying an older, slower completion pattern can then overstate ultimate claims; a slowdown can produce the reverse bias. Examine inventory counts, receipt-to-payment times, electronic submission rates, and development by claim category. Distinguish a permanent processing improvement from a temporary backlog clearance. Calendar-period diagnostics are useful because one operational event can affect several incurred cohorts simultaneously.
Worked example: Historically, a cohort was 50% paid after two months. A new platform increases completion to 60%. With $6 million paid, the old pattern implies $12 million ultimate, while the adjusted pattern implies $10 million. The difference arises from timing, not necessarily morbidity.
Common mistake: Interpreting every increase in early paid claims as higher ultimate utilization confuses claim processing speed with changes in benefit cost.
Official syllabus reference: [1]
8. Trend from Experience Midpoint to Projection Midpoint
Trend moves an experience cost level to the period being estimated. With annual effective trend t and a midpoint separation of m months, the factor is (1+t) raised to m/12. Use member-weighted midpoints when exposure is uneven. Distinguish medical price changes, utilization changes, and service intensity where the data support decomposition. Trend does not repair incomplete development or benefit differences; those require separate adjustments. Applying several adjustments is defensible only when their scopes are clear and the same cost change is not counted twice.
Worked example: Completed experience costs $300 PMPM and its weighted midpoint is eighteen months before the projection midpoint. At 6% annual trend, projected cost is $300 times 1.06 raised to 1.5, approximately $327.40 PMPM, before benefit or population changes.
Common mistake: Using the number of calendar years touched by two periods instead of their midpoint separation can materially overstate or understate trend.
Official syllabus reference: [1]
9. Seasonality Versus Claim Development
Seasonality describes recurring differences in incurred cost across calendar periods; development describes how an incurred cohort becomes reported or paid. Influenza activity, elective care schedules, working days, and deductible accumulation can affect seasonal cost patterns. Normalize seasonal indices to the intended annual exposure basis so adjustments do not inadvertently change the annual total. Separating service-date patterns from payment-date patterns is essential: a winter payment spike can reflect earlier services or processing schedules rather than winter utilization. Benefit design changes can also alter historical seasonal relationships.
Worked example: An annual average is $250 PMPM. A January seasonal index of 1.08 implies $270 PMPM for January before trend. That expected incurred cost is then developed using January's payment pattern; the seasonal index does not itself indicate how much has been paid.
Common mistake: Using a seasonal cost index as a completion factor treats variation in incurred services as though it measured payment timing.
Official syllabus reference: [1]
10. Exposure and Risk-Mix Standardization
Aggregate PMPM changes can arise because subgroup costs changed or because enrollment shifted toward more expensive groups. Standardization holds subgroup weights constant to isolate underlying cost movement. Calculate subgroup-specific estimates using consistent benefits and exposures, then apply the desired population weights. Enrollment files should distinguish eligible members from covered member months and address retroactive changes. A blended historical completion pattern can also become unsuitable when the current mix shifts toward services with different payment lags. Mix adjustment therefore affects both ultimate cost expectations and development selection.
Worked example: Adult and child costs are $400 and $150 PMPM. A 50:50 population averages $275, while a 60:40 population averages $300 without any subgroup cost increase. Attributing the entire $25 change to trend would mistake enrollment composition for worsening unit costs.
Common mistake: Treating every aggregate PMPM increase as medical inflation overlooks changes in age, benefit, geography, and other risk-group proportions.
Official syllabus reference: [1]
11. Large Claims and Gross-to-Net Recovery
Large claims can dominate small cohorts and may develop differently from routine claims. Separate known high-cost cases when doing so improves estimation, then reconcile them with the ordinary-claim model to prevent duplication. Estimate gross obligations before applying contractual reinsurance terms, including retention, covered expenses, limits, and recoverability. A pooling adjustment used to stabilize experience is not automatically an actual receivable. Distinguish the statistical treatment of outliers from legally collectible recoveries and consider the timing difference between paying a claim and receiving reimbursement.
Worked example: A known claim is expected to cost $900,000. A treaty reimburses eligible costs above a $250,000 retention with no relevant limit. Expected recovery is $650,000 and net claim cost is $250,000, assuming all costs qualify and collection is supported.
Common mistake: Subtracting a statistical pooling charge as though it were a contractual recovery understates liabilities when no corresponding reimbursement right exists.
Official syllabus reference: [1]
12. Reserve Runout and Retrospective Adequacy
A retrospective reserve test compares an earlier unpaid estimate with later payments for the same incurred obligations plus any remaining unpaid estimate. This measures prior reserve adequacy rather than the current period's claim level. Preserve the original valuation basis and separately identify data corrections, assumption changes, and new information. Repeated favorable or adverse development can reveal systematic bias, but one cohort may reflect random variation. Analyze differences by development age and business segment, and recognize that the latest estimate of ultimate claims can itself remain uncertain.
Worked example: A prior year-end reserve was $5 million. Subsequent payments for those services total $4.3 million, and $0.4 million remains unpaid. The revised obligation is $4.7 million, indicating $0.3 million favorable development, assuming unchanged scope and no omitted recoveries.
Common mistake: Comparing a prior reserve only with subsequent payments declares premature redundancy whenever meaningful liabilities remain unpaid at the review date.
Official syllabus reference: [1]
13. Estimating Future Claim Settlement Expenses
A claim settlement expense reserve funds future work needed to resolve claims already incurred. Direct costs may include claim review, investigation, and appeals; attributable indirect costs may include supervision and systems support. Estimate these obligations using drivers of remaining work, such as unsettled claim counts, complexity, and expected handling time. Reported and unreported claims can both require future effort. A percentage of benefit reserves may be unreliable when automation or claim mix changes the relationship between benefit dollars and administrative work. Exclude expenses already paid and avoid counting support costs twice.
Worked example: A dental insurer expects 700 incurred claims still to require processing, at $18 of future handling expense each. Attributable support costs add $5,400 and are excluded from the unit cost. The required settlement expense reserve is 700 × $18 + $5,400 = $18,000.
Common mistake: Assuming a smaller benefit reserve guarantees lower settlement expenses overlooks claim counts and complexity; numerous low-dollar disputed claims can require substantial remaining work.
Official syllabus reference: [1]
14. Premium Deficiency Reserves for Unexpired Coverage
A premium deficiency test evaluates whether resources associated with unexpired coverage are sufficient for expected future claims and applicable expenses. Relevant resources, investment income treatment, grouping, and acquisition-cost interactions depend on the accounting basis. The additional liability is distinct from unpaid claims for services already incurred. Specify the test before calculating it, and avoid offsetting losses with unrelated profitable business when that grouping is not permitted. ASOP 42 is relevant to health actuarial assets and liabilities other than incurred claims, while the syllabus separately includes premium deficiency readings.
Worked example: Under a specified test, future claims and expenses total $9 million. Future premiums and an existing unearned premium liability provide $8.2 million. With no other permitted offsets, an additional $0.8 million liability is needed for the unexpired coverage.
Common mistake: Using premium deficiency reserves to replace incurred claim liabilities mixes future coverage obligations with services that have already occurred.
Official syllabus reference: [1]
15. Unearned Premium and Coverage Earning Patterns
Unearned premium represents premium associated with coverage not yet provided. For uniform risk over a fixed coverage period, time-based earning can be appropriate: written premium less the increase in unearned premium gives earned premium, after other necessary adjustments. Nonuniform coverage or benefit patterns may require a different earning approach. Unearned premium is not an estimate of incurred claims and is not equivalent to premium receivables. Receivables concern amounts owed, while earning concerns the period in which insurance protection is supplied.
Worked example: A $1,200 annual policy begins October 1 and earns uniformly by month. At December 31, three months are earned, producing $300 earned premium and $900 unearned premium. Whether the customer has paid the bill is a separate receivable question.
Common mistake: Recognizing every collected premium immediately as revenue ignores future coverage obligations and makes income depend on billing and collection timing.
Official syllabus reference: [1]
16. Disabled-Life Reserves and Claim Termination
A disabled-life reserve values future benefits arising from a disability already incurred. Expected payments depend on benefit amounts, elimination and maximum benefit periods, contractual offsets, and termination through recovery, death, or other eligibility cessation. Discount each payment using probabilities consistent with its timing. Unconditional continuation probabilities already reflect survival from the valuation date and should not be multiplied successively. The reserve is sensitive to persistence: longer expected claim duration generally increases liability. Expenses and future premiums require explicit treatment rather than an automatic inclusion or exclusion.
Worked example: A claimant may receive $20,000 one year from now with 80% probability. At 4% interest, the benefit's expected present value is $20,000 times 0.80 divided by 1.04, approximately $15,385. Additional possible payments require their own timing and continuation probabilities.
Common mistake: Applying active-life incidence rates to an approved disability claim misstates the problem because the insured event has already occurred.
Official syllabus reference: [1]
17. Active-Life Contract Reserves and Level Premiums
An active-life contract reserve can arise when a contract's premium pattern does not match its expected future benefit pattern. A prospective formulation compares the present value of future benefits and applicable expenses with future valuation premiums under the relevant basis. Level premiums may collect more than expected current costs early and less later as morbidity rises. This mechanism differs from a disabled-life reserve for an existing claim. Whether a contract reserve is required, and which assumptions apply, depends on product features and the governing accounting requirements.
Worked example: Under an illustrative valuation basis, an active policy has $12,000 present value of future benefits and expenses and $9,500 present value of future valuation premiums. The prospective reserve is $2,500, even though the policyholder currently has no reported disability or medical claim.
Common mistake: Concluding that an active insured needs no reserve overlooks contracts whose level premiums must support higher expected costs in later years.
Official syllabus reference: [1]
18. Cash-Flow Adequacy and Actuarial Communication
Cash-flow analysis evaluates whether assets and future inflows can meet obligations across time, rather than merely whether one valuation-date total appears sufficient. ASOP 7 addresses life or health cash-flow analysis, and ASOP 41 addresses actuarial communications. Project claim, premium, expense, investment, and recovery timing under relevant scenarios. A report should identify purpose, methods, assumptions, material limitations, and uncertainty sufficiently for intended users. A central estimate can be adequate on average yet expose a liquidity shortfall when claims accelerate or recoveries arrive later than expected.
Worked example: An insurer holds $10 million against $9 million of expected payments, but $7 million is due next month and only $4 million is readily available. A timing projection reveals a liquidity issue that comparing the two year-end totals would miss.
Common mistake: Describing a reserve as sufficient solely because assets exceed liabilities ignores payment timing and obscures the assumptions users need to assess adequacy.
Official syllabus reference: [1]
Financial Statements
19. The Insurance Balance-Sheet Equation
The balance sheet measures assets, liabilities, and the residual ownership or surplus interest at a point in time. Under statutory reporting, admitted assets less recognized liabilities determine statutory surplus. Under GAAP, recognition and measurement differences can produce a different asset, liability, and equity presentation. A balance-sheet improvement should be traced to its source: earnings, capital contribution, valuation change, or recognition adjustment. Comparing totals without reconciling reporting bases can mislead stakeholders about financial strength, particularly when an apparent improvement provides no additional cash or risk-bearing resources.
Worked example: An insurer reports $100 million of admitted assets and $82 million of liabilities, leaving $18 million surplus. A $3 million capital contribution raises assets and surplus to $103 million and $21 million if no other transaction changes the balance sheet.
Common mistake: Treating surplus as a separate pot of assets double counts resources because surplus is the residual interest in already recognized assets.
Official syllabus reference: [1]
20. Written, Collected, and Earned Premium
Collected premium measures cash receipts, written premium measures premium recorded for policies or coverage, and earned premium measures the portion attributable to protection already provided. With no other adjustments, written premium equals collections plus the increase in premium receivables; earned premium equals written premium less the increase in unearned premium liabilities. Refunds, write-offs, retrospective adjustments, and reinsurance can require additional bridge items. Distinguishing the measures supports meaningful loss ratios and prevents payment schedules from distorting the apparent profitability of coverage provided during the reporting period.
Worked example: Collections are $20 million and premium receivables increase $1 million, producing $21 million written premium. If unearned premium increases $2 million, earned premium is $19 million. The three figures differ because billing, collection, and coverage earning occur on different schedules.
Common mistake: Using premium collections as the loss-ratio denominator can make identical insurance coverage appear more profitable merely because customers paid earlier.
Official syllabus reference: [1]
21. Incurred Claims and Prior-Period Development
For a consistent scope, incurred claim expense equals claim payments plus ending unpaid claim liabilities minus beginning unpaid claim liabilities. The expense can contain both current-period claims and revisions to prior-period estimates. Favorable prior development reduces current reported expense but does not necessarily indicate improved current underwriting. Reinsurance, foreign exchange, portfolio transfers, or accounting changes can require separate reconciliation. An analyst should separate accident or service period from financial reporting period when interpreting loss-ratio changes and assessing whether earnings are repeatable.
Worked example: Payments are $40 million, opening unpaid liabilities are $12 million, and closing liabilities are $15 million. Incurred expense is $43 million. If that includes $2 million favorable prior development, current-period claim cost before that release is $45 million.
Common mistake: Interpreting a lower reported loss ratio as better current experience can overlook reserve releases attributable to earlier service periods.
Official syllabus reference: [1]
22. Deferred Acquisition Costs and Expense Timing
GAAP may defer qualifying acquisition costs for applicable contracts and recognize them through an appropriate amortization pattern, while other expenditures are expensed immediately. Eligibility is narrower than simply being incurred near a sale. Statutory treatment can create greater initial acquisition strain, depending on the applicable rules. Deferral changes the timing of expense recognition and creates an asset; it does not reduce cash spending. Recoverability and premium deficiency considerations can constrain the asset. Always identify contract classification and accounting basis before assuming a particular cost qualifies or amortizes in a particular way.
Worked example: Of $500,000 acquisition spending, an exercise identifies $300,000 as deferrable. If 40% is amortized during the year, expense is $200,000 plus $120,000, or $320,000, and the remaining deferred asset is $180,000. Cash outflow remains $500,000.
Common mistake: Capitalizing all marketing and overhead spending merely because it supports sales overstates the deferred asset and understates current expense.
Official syllabus reference: [1]
23. Asset Admissibility and Statutory Surplus
Statutory accounting distinguishes assets that qualify for admission from those excluded from the admitted asset total. The distinction reflects statutory recognition requirements and policyholder-protection objectives, rather than a simple declaration that excluded assets are economically worthless. Nonadmission can reduce statutory surplus without changing cash or the underlying asset's existence. Limits and eligibility depend on asset type and applicable rules. Reconcile statutory and GAAP presentations explicitly when analyzing capital, and do not assume that a reported asset can always be realized promptly to pay claims.
Worked example: An insurer acquires a $200,000 asset that is fully nonadmitted under the exercise's assumptions. Paying cash reduces admitted assets by $200,000 without creating an offsetting admitted asset, reducing statutory surplus by that amount even though the insurer still owns the purchased item.
Common mistake: Equating book ownership with statutory admission ignores recognition restrictions and can overstate the resources included in reported statutory surplus.
Official syllabus reference: [1]
24. Operating Cash Flow Versus Accrual Profit
Profit recognizes revenue and expense under the accounting basis; cash flow records actual receipts and payments. Growing claim liabilities can temporarily support cash while reducing earnings, and collecting receivables can improve cash without creating new revenue. Analyze both measures when assessing liquidity and sustainability. A cash-flow bridge should identify movements in receivables, unearned premiums, claim liabilities, and other working-capital items. Strong cash flow caused by delayed claims is different from durable underwriting profitability and may reverse rapidly when the payment backlog clears.
Worked example: An insurer earns $10 million premium and incurs $9 million claims, producing $1 million before other expenses. If it collects all premiums but pays only $7 million claims, cash inflow less claims is $3 million and unpaid claims increase $2 million.
Common mistake: Calling the entire cash surplus profit ignores unpaid obligations and can encourage distributions of funds needed for already incurred claims.
Official syllabus reference: [1]
25. Loss, Expense, and Combined Ratios
A loss ratio compares incurred claims with a specified premium denominator, commonly earned premium. Expense ratios measure defined expenses relative to the selected premium base, and a combined ratio combines compatible loss and expense measures. Specify treatment of claim adjustment expenses, commissions, reinsurance, and investment income before comparison. A combined ratio below 100% indicates underwriting profit only under the defined scope; it is not automatically equivalent to an ACA medical loss ratio or a statutory filing metric. Trend analysis requires consistent definitions across periods and companies.
Worked example: Earned premium is $50 million, incurred claims are $41 million, and included operating expenses are $7 million. On a common earned-premium basis, the loss ratio is 82%, expense ratio 14%, and combined ratio 96%, leaving $2 million underwriting income.
Common mistake: Comparing a regulatory medical loss ratio directly with an unadjusted accounting loss ratio ignores differences in permitted numerator and denominator adjustments.
Official syllabus reference: [1]
26. Premium Required for a Target Margin
When variable expenses and target margin are expressed as percentages of premium, solve for premium algebraically. If claims plus fixed expenses equal C and the combined premium-based load is v, required premium is C divided by (1-v). Multiplying C by (1+v) applies the load to costs rather than final premium and understates the indicated amount. Projection also requires consistent exposure, benefit, and trend assumptions. A target margin is a pricing assumption, not a universal regulatory requirement or a guarantee that actual results will meet the target.
Worked example: Projected claims are $400 PMPM and fixed expenses $20 PMPM. Variable expenses are 5% of premium and target margin is 3%. Required premium is $420 divided by 0.92, approximately $456.52 PMPM, which funds both percentage-based provisions.
Common mistake: Adding eight percent to claim and fixed costs produces a load on costs, rather than the requested eight percent of final premium.
Official syllabus reference: [1]
27. Quota-Share Reinsurance and Ceding Commissions
Quota-share reinsurance transfers a stated proportion of covered premiums and claims, subject to treaty terms. A ceding commission compensates the cedent for expenses or other agreed economics; it is not automatically equal to actual retained expenses. Calculate net underwriting results using ceded premium, ceded claims, commissions, and expenses separately. Reinsurance can reduce volatility or capital requirements while also surrendering expected margin and creating counterparty exposure. Capital and accounting recognition depend on contract substance and applicable requirements, so a treaty label alone does not establish the desired financial treatment.
Worked example: A 30% quota share on $10 million premium and $8 million claims cedes $3 million premium and $2.4 million claims. A 10% commission on ceded premium returns $300,000. Before expenses, retained underwriting contribution is $1.7 million rather than $2 million gross.
Common mistake: Applying the quota-share percentage to all operating expenses assumes expense transfer that may not exist in the actual treaty.
Official syllabus reference: [1]
28. Health RBC Components H0 Through H4
U.S. health RBC organizes requirements into H0 affiliate asset risk, H1 other asset risk, H2 underwriting risk, H3 credit risk, and H4 business risk. Completed component amounts feed the company-action-level aggregation: H0 + sqrt(H1² + H2² + H3² + H4²). Affiliate risk is added outside the covariance square root. Underlying worksheets apply detailed factors and adjustments, so component aggregation does not replace those schedules. Analyze which exposure drives a requirement before proposing capital relief; reducing claim volatility may affect H2 while adding a reinsurer receivable can introduce H3 exposure.
Worked example: Suppose H0 is $1 million, H1 is $3 million, H2 is $4 million, and H3 and H4 are zero. Company-action-level RBC is $1 million plus the square root of 9 plus 16, or $6 million, rather than the $8 million component sum.
Common mistake: Adding all health RBC components directly ignores covariance, while placing H0 inside the square root changes the prescribed aggregation structure.
Official syllabus reference: [1]
29. Total Adjusted Capital and the ACL RBC Ratio
The health RBC ratio commonly compares total adjusted capital, or TAC, with authorized-control-level RBC, or ACL RBC. ACL RBC is one-half of company-action-level RBC. Identify both numerator and denominator explicitly: statutory surplus and TAC are related but can differ through prescribed adjustments. A ratio improves when TAC rises or required capital falls, and these changes have different economic meanings. RBC is a regulatory capital framework rather than a complete economic-capital model. Interpret it alongside liquidity, concentration, earnings quality, and risks not fully captured by formula factors.
Worked example: Company-action-level RBC is $8 million, making ACL RBC $4 million. With TAC of $14 million, the ratio is 350%. Dividing by $8 million instead would produce 175%, a different denominator convention rather than a sudden change in capital resources.
Common mistake: Reporting an RBC percentage without naming its denominator makes comparisons unreliable and can create a factor-of-two misunderstanding of capital strength.
Official syllabus reference: [1]
30. Structured Reinsurance and Risk-Transfer Substance
Structured reinsurance can alter the timing and distribution of financial results through experience accounts, loss corridors, aggregate limits, financing features, or contingent payments. Evaluate the full contract's economic substance rather than its title or initial cash transfer. A financing arrangement may provide cash without transferring sufficient insurance risk for the intended accounting treatment. Project adverse as well as expected scenarios, including repayment obligations and termination provisions. A useful assessment reconciles economic risk transfer, reported income, cash flow, and capital effects instead of assuming that improvement in one measure proves improvement in all.
Worked example: A treaty advances $5 million but requires nearly complete repayment through future experience adjustments. The initial cash receipt improves liquidity. A scenario analysis must determine what losses the reinsurer actually bears before treating the transaction as equivalent to an unrestricted transfer of claim risk.
Common mistake: Assuming an upfront reinsurance payment is immediate profit overlooks repayment terms and the accounting consequences of limited substantive risk transfer.
Official syllabus reference: [1]
31. Reinsurance Recoverables and Collection Risk
A reinsurance recoverable reflects amounts expected from a reinsurer under contractual terms, but its recognition and measurement require more than estimating gross claims. Confirm coverage, attachment, limits, exclusions, disputes, and collectibility. Distinguish recoveries already due from estimates associated with unpaid claims. Gross-to-net presentation should preserve the cedent's obligation to policyholders where applicable; reimbursement does not necessarily discharge that obligation. Counterparty concentration and payment delays can create credit and liquidity risks even when the underlying covered claim calculation is accurate.
Worked example: An insurer owes $4 million on covered claims and expects $1.5 million reimbursement. Net economic exposure is $2.5 million if collectible, but the insurer may still need to fund the full $4 million before recovery. A disputed $300,000 portion needs separate collectibility assessment.
Common mistake: Reducing cash needs immediately by an estimated recoverable ignores reimbursement timing and the possibility that the reinsurer contests or delays payment.
Official syllabus reference: [1]
32. Reserve Strengthening Through Earnings and Capital
Increasing an unpaid claim liability raises claim expense and reduces pretax income when no offsetting item changes. The resulting reduction in retained earnings or surplus can also weaken capital ratios. The exact after-tax effect depends on tax recognition and admissibility, while required capital may itself change. Separate the accounting impact from the operational cause: strengthening can reflect new information, a method correction, or changed assumptions rather than current-period utilization alone. Management projections should reconcile income, balance sheet, and capital effects under the same reserve scenario.
Worked example: An insurer increases unpaid claims by $2 million with no asset or tax offset. Pretax income and surplus each fall $2 million. If TAC falls from $12 million to $10 million while ACL RBC remains $4 million, the RBC ratio declines from 300% to 250%.
Common mistake: Treating reserve strengthening as only a balance-sheet change misses the associated expense recognition and its potential effect on reported capital.
Official syllabus reference: [1]
33. ASOP 21 Support for Auditors and Examiners
ASOP 21 concerns actuaries responding to or assisting auditors or examiners in financial work. Useful support connects reported amounts with data, methods, assumptions, controls, and relevant changes. Clarify the scope of the request and the respective responsibilities rather than implying that actuarial assistance constitutes an audit opinion. Explain material uncertainty and provide reproducible reconciliations. Strong financial communication also distinguishes facts from judgments: a booked reserve, an actuarial estimate, and a management adjustment may differ, and the reviewer needs a transparent bridge among them.
Worked example: An auditor asks why claim liabilities rose $6 million. The actuary supplies a bridge separating exposure growth, later payment completion, revised trend, and a management adjustment. Supporting exhibits reconcile the actuarial model to the ledger rather than presenting only the model's final number.
Common mistake: Sending a final reserve total without its scope, assumptions, and ledger reconciliation leaves the reviewer unable to assess what the number represents.
Official syllabus reference: [1]
Regulation
34. Statutes, Regulations, and Agency Implementation
A statute establishes legal authority and obligations through the legislative process. Agencies implement delegated authority through regulations, guidance, approvals, examinations, and enforcement, subject to applicable legal constraints. Federal and state responsibilities can overlap, so identify the regulated entity, product, activity, jurisdiction, and effective date. A proposed rule is different from a final rule, and a future effective date is different from a current requirement. Actuarial analysis should connect the operative requirement to pricing, benefits, reporting, or capital rather than treating every policy announcement as immediately binding.
Worked example: A legislature authorizes rate review, and the insurance department issues filing rules under that authority. An insurer's analysis must address the final applicable rule and its effective date. A public proposal to amend the filing process does not by itself change today's submission requirements.
Common mistake: Applying a proposed policy as though it were an effective regulation can misstate obligations and distort the timing of financial projections.
Official syllabus reference: [1]
35. State Solvency Oversight and Policyholder Protection
State insurance solvency regulation evaluates whether insurers can meet policyholder obligations. Tools include licensing, financial reporting, reserve requirements, asset restrictions, examinations, and risk-based capital oversight. Financial strength is broader than one profit measure: an insurer can report earnings while holding illiquid assets or inadequate claim liabilities. State requirements and intervention processes should be identified for the relevant entity rather than assumed uniform in every detail. Actuarial work supports oversight by connecting liabilities, capital, and adverse scenarios with the insurer's actual business and risk concentrations.
Worked example: Two insurers each earn $5 million, but one has substantially weaker surplus and concentrated illiquid investments. A solvency assessment examines those differences rather than ranking both identically by earnings. Reserve adequacy and claim-payment liquidity can materially change the policyholder-protection conclusion.
Common mistake: Equating positive annual earnings with solvency overlooks the stock of obligations, asset quality, liquidity, and accumulated capital supporting the insurer.
Official syllabus reference: [1]
36. Rate and Form Review as Distinct Controls
Rate review examines premium levels and supporting assumptions under applicable requirements, while form review concerns policy language, benefits, exclusions, and contractual compliance. The applicable process varies by product and jurisdiction; approval, filing, or other treatment should not be generalized across all health coverage. A rate indication needs credible experience, projection assumptions, expenses, and a clear benefit basis. Form changes can alter expected claims and therefore the rate analysis. Approval within one scope does not establish compliance with unrelated solvency, federal-benefit, network, or drug-approval requirements.
Worked example: An insurer revises a policy to cover an additional therapy. The form analysis addresses the contractual benefit wording, while the rate analysis estimates its claim-cost effect. Retaining the old premium justification without incorporating the new benefit leaves the two submissions inconsistent.
Common mistake: Treating approval of policy wording as validation of premium adequacy confuses contractual compliance with the separate financial assumptions supporting rates.
Official syllabus reference: [1]
37. ERISA's Saving and Deemer Provisions
ERISA generally preempts state laws relating to covered employee benefit plans, subject to important qualifications. Its insurance saving provision preserves state regulation of insurance, while its deemer provision generally prevents self-funded ERISA plans from being treated as insurers for that purpose. Consequently, state insured-policy mandates can affect purchased coverage without applying identically to a self-funded plan. Employer stop-loss coverage is a separate insurance contract and does not automatically make employee benefits fully insured. Federal obligations still require analysis, and these principles do not exempt self-funded plans from every state-law effect.
Worked example: A private employer buys an insured group policy subject to an applicable state benefit mandate. Another self-funds an ERISA plan and purchases employer stop-loss. The mandate's route through the insurer differs from direct regulation of the self-funded plan, even though both employers manage health costs.
Common mistake: Calling every plan with stop-loss fully insured confuses protection of the employer's finances with insurance providing benefits directly to employees.
Official syllabus reference: [1]
38. ACA Market Rules and Product Classification
ACA obligations depend on market segment, funding arrangement, product status, and the particular provision. Individual and small-group rating and benefit rules should not be assumed identical to every large-group or self-funded requirement. Guaranteed availability and limits on health-status rating change how insurers can respond to risk selection, increasing the importance of pooled pricing and risk adjustment. Identify the applicable rule before modeling its financial effect. Avoid substituting one familiar ACA requirement for the full analysis of eligibility, benefit design, enrollment, rating, and filing obligations.
Worked example: An insurer cannot evaluate a proposed individual-market rating factor merely by showing that it predicts claims. It must first determine whether that factor is permitted in the applicable market. Predictive accuracy and legal rating permissibility answer different questions about the proposed premium structure.
Common mistake: Assuming a medically predictive variable is automatically a permissible premium factor overlooks market-specific restrictions on how health insurance may be rated.
Official syllabus reference: [1]
39. HIPAA Privacy and Actuarial Data Use
HIPAA privacy requirements govern protected health information for covered entities and relevant business associates, with permitted uses and disclosures depending on the purpose and circumstances. Actuarial analysis does not itself eliminate privacy obligations. Identify the information needed, the legal basis for access, safeguards, and any applicable minimum-necessary requirement. Removing a name alone does not necessarily de-identify a dataset because other fields can identify a person. Privacy protection should preserve needed analytical utility through appropriate aggregation or controlled access rather than an unsupported claim that all health data sharing is prohibited.
Worked example: A pricing team requests individual claims containing names, birth dates, and diagnoses. Analysts determine which fields the approved analysis actually needs and arrange authorized access or suitable de-identification. A file without names can still contain combinations of dates and locations that identify members.
Common mistake: Assuming a nameless claims file is automatically de-identified ignores remaining identifiers and combinations of fields that may reveal individual identities.
Official syllabus reference: [1]
40. COBRA Continuation and Selection Effects
COBRA provides continuation opportunities for qualifying coverage following specified events when its requirements apply. Eligibility, notices, election periods, duration, and permitted premiums require the applicable legal facts; do not impose one duration on every event. From an actuarial perspective, continuation election is selective: people anticipating substantial claims may value coverage more highly than healthier former participants. Compare continuation claims and premiums on a consistent exposure basis, and recognize that small cohorts can be volatile. The financial effect depends on election behavior, permitted premium structure, and integration with the wider plan.
Worked example: A plan's former employees who elect continuation average $900 PMPM in claims, compared with $500 for active employees. The difference may reflect selective election rather than a processing error. A projection should examine continuation-specific exposure and premium recovery instead of applying active costs uncritically.
Common mistake: Assuming continuation enrollees are a random sample of departing employees overlooks the relationship between expected medical needs and election decisions.
Official syllabus reference: [1]
41. FDA Approval Versus Coverage and Payment
FDA approval concerns whether a drug satisfies the applicable regulatory evidence requirements for its approved use. Insurance coverage and payment involve additional questions, including benefit terms, medical-necessity criteria, formulary structure, and applicable coverage law. Approval does not by itself establish a universal reimbursement amount or require every plan to cover every use. Conversely, an actuarial estimate of affordability does not establish safety or effectiveness. Drug forecasts should distinguish regulatory approval, market entry, benefit placement, and utilization management because each can change the timing and magnitude of paid claims.
Worked example: A newly approved therapy may become available before a plan completes its permitted formulary review. The forecast separately estimates approval timing, eligible patients, benefit coverage, negotiated price, and uptake rather than assuming every eligible patient receives a paid treatment immediately after approval.
Common mistake: Treating drug approval as a universal insurance coverage decision collapses distinct regulatory, contractual, and payment questions into a single event.
Official syllabus reference: [1]
42. Patents and Regulatory Exclusivity as Separate Barriers
Patents protect qualifying inventions through patent law, while regulatory exclusivity arises through drug-regulatory provisions and can restrict specified approval pathways or timing. Their scopes, start dates, and durations differ, and they can overlap. A competitor may need to address both protections as well as its own approval requirements. Model the latest unresolved barrier under the actual facts rather than adding all protection periods consecutively. Patent expiration also does not guarantee immediate entry, substantial uptake, or a particular discount, because manufacturing, litigation, and commercial constraints can remain.
Worked example: In a hypothetical forecast, exclusivity ends in 2028 but a valid blocking patent lasts through 2030. Removing the patent in a sensitivity does not erase the 2028 exclusivity date. The earliest entry estimate must also consider when the competitor can obtain approval.
Common mistake: Using patent expiration as the sole competition date ignores regulatory exclusivity and other barriers that can independently delay market entry.
Official syllabus reference: [1]
43. Secondary Patents and Pharmaceutical Entry Scenarios
Pharmaceutical products can be associated with patents on different features, such as an active ingredient, formulation, delivery device, or method of use. A portfolio may complicate entry even after an original patent expires, but a patent's existence does not prove that it validly blocks every competing product. Distinguish lawful protection of qualifying innovation from allegations of strategic abuse. For actuarial forecasting, use documented legal assessments to construct entry scenarios, then separately estimate price and utilization effects. Avoid assuming that every secondary patent automatically extends all protection to its latest expiry.
Worked example: An original compound patent expires in 2029 and a device patent in 2033. A competitor proposing a different device may face a different entry path from one copying the patented device. The financial forecast therefore uses alternative entry dates supported by the product-specific legal analysis.
Common mistake: Selecting the latest patent date without considering claim scope assumes every listed patent blocks every possible competitor in the same way.
Official syllabus reference: [1]
44. State Drug and PBM Regulation
States can regulate aspects of prescription-drug markets through insurance, pharmacy, and pharmacy-benefit-manager requirements, within applicable federal constraints. Requirements can affect contracting, reporting, network access, reimbursement practices, or cost-sharing administration, but their scope varies. Identify whether a provision targets an insurer, PBM, pharmacy, or benefit plan before estimating its effect. A rule changing a rebate or reimbursement practice can redistribute funds without reducing underlying drug utilization. Federal preemption and program-specific requirements need separate analysis rather than an assumption that every state measure reaches every health arrangement equally.
Worked example: A hypothetical state rule changes reporting obligations for PBMs serving insured products. The insurer estimates new administrative costs and possible contract changes, while separately determining whether the same provision applies to its self-funded clients. The analysis does not presume identical reach across both arrangements.
Common mistake: Applying a state PBM requirement to every client without checking the regulated entity and funding arrangement can misstate both compliance costs and legal scope.
Official syllabus reference: [1]
45. Gene Therapy Pricing and Payer Fragmentation
Gene therapies can concentrate substantial costs at treatment while benefits and uncertainty extend for years. Fragmented insurance enrollment means the payer funding treatment may not capture all later avoided costs. U.S. and European regulatory and market structures differ in purchasing, assessment, and negotiation, but no single explanation determines every price difference. Evaluate eligible population, clinical durability, treatment timing, and contract enforceability. Outcomes-based refunds or installment arrangements change risk allocation and cash timing; they do not automatically establish affordability, adequate insurance risk transfer, or equivalent access across jurisdictions.
Worked example: An insurer pays $2 million for treatment and expects future avoided claims, but the member may change insurers next year. A two-year refund provision requires explicit rules for tracking outcomes and assigning refund rights after disenrollment before the expected recovery can be valued reliably.
Common mistake: Crediting one insurer with every lifetime avoided claim ignores member movement and can overstate the financial return from an upfront therapy payment.
Official syllabus reference: [1]
Government Programs
46. Medicare Parts A and B: Services and Financing
Medicare Part A principally covers inpatient hospital care, qualifying skilled nursing facility care, hospice, and certain home health services. Part B principally covers physician and outpatient services, preventive services, durable medical equipment, and certain home health services. Eligibility and coverage conditions matter; a facility's name alone does not classify every claim. Part A's Hospital Insurance financing relies heavily on payroll taxes. Part B is financed mainly through general revenues and beneficiary premiums. Distinguish benefit classification from financing and from the separate choice between Original Medicare and Medicare Advantage.
Worked example: A beneficiary has an inpatient hospital stay followed by an outpatient cardiology visit. Under the stated covered-service assumptions, the hospital facility claim belongs principally to Part A and the cardiologist's outpatient service to Part B. A physician service during hospitalization can also fall under Part B.
Common mistake: Assigning every hospital-related bill to Part A overlooks separately billed physician services and outpatient hospital care generally associated with Part B.
Official syllabus reference: [1]
47. Medicare Advantage Bid-Benchmark Funding
A Medicare Advantage bid represents the plan's required revenue for Medicare-covered benefits under the applicable bid framework. Comparing it with the benchmark determines important financing consequences. A below-benchmark bid generates a rebate equal to the applicable percentage of the difference, supporting permitted benefits or premium reductions. An above-benchmark bid generally creates an additional beneficiary premium. Risk adjustment and other payment rules modify actual revenue, so the simple comparison is a foundation rather than a complete payment calculation. Keep Part D and separately priced supplemental benefits distinct when constructing the funding bridge.
Worked example: With a $1,000 PMPM benchmark, a $900 bid, and an assumed 60% rebate percentage, the rebate is $60 and simplified government funding is $960 PMPM. A $1,040 bid instead implies $40 PMPM additional beneficiary premium under an otherwise unadjusted comparison.
Common mistake: Treating the full benchmark-minus-bid difference as unrestricted plan profit ignores the rebate percentage and restrictions on how rebate amounts support beneficiaries.
Official syllabus reference: [1]
48. Medicare Advantage Risk Scores and Experience Pitfalls
Medicare Advantage risk adjustment changes payments to reflect measured differences in expected beneficiary cost under the applicable model. A risk score is not a direct measurement of every future claim and can be affected by diagnosis capture, data completeness, model changes, and population turnover. Experience analysis should align claims, enrollment, risk scores, and payment periods. Separating coding effects from morbidity changes is essential for projections. Avoid multiplying revenue by a risk-score change while leaving all other assumptions unquestioned, particularly when the underlying population or payment model has also changed.
Worked example: A plan's average risk score rises from 1.00 to 1.08 while claims rise only 3%. Analysts investigate whether the difference reflects diagnosis capture, timing, or population change. They do not automatically interpret the eight-percent score increase as eight-percent deterioration in underlying health.
Common mistake: Reading risk-score growth as a pure morbidity trend overlooks coding, model, and enrollment effects that can change measured risk independently.
Official syllabus reference: [1]
49. ESRD Populations in Medicare Advantage Projections
Expanded Medicare Advantage eligibility for people with end-stage renal disease increased the importance of modeling dialysis-related costs and payment characteristics. Separate prevalence, incident cases, treatment settings, transplant pathways, and mortality or disenrollment where appropriate. Historical aggregate experience may poorly represent a changing ESRD mix. Payment adjustments and provider contracting need analysis alongside claims rather than an assumption that high costs are perfectly offset. A small number of members can materially affect results, making cohort-specific exposure, high-cost variability, and operational access important elements of a credible projection.
Worked example: A plan expects ESRD enrollment to increase from 40 to 80 member-years. If its existing average medical PMPM excludes most dialysis experience, applying that average to the added members understates projected claims. A separate ESRD cost and revenue build-up makes the enrollment effect visible.
Common mistake: Assuming aggregate risk adjustment exactly offsets every ESRD member's cost ignores individual variation, contracting differences, and limitations of population-level payment models.
Official syllabus reference: [1]
50. Medicaid Federal-State Structure and Benefit Scope
Medicaid is jointly financed by federal and state governments and administered by states within federal requirements and approved program arrangements. Eligibility groups, covered benefits, delivery systems, and payment methods vary. A managed care contract may include some services while carving out others for separate payment. Before analyzing experience, identify the enrolled population, benefit package, and contractual responsibility for each service. Federal matching funds help finance state program expenditures; they are not an additional provider service purchase. Avoid assuming that one state's arrangement represents every Medicaid program or eligibility category.
Worked example: A state contracts with a managed care organization for acute services but pays certain pharmacy benefits separately. The capitation base must exclude the carved-out pharmacy claims while retaining any pharmacy-related responsibilities actually included in the contract. Total Medicaid spending still includes both funding channels.
Common mistake: Using all Medicaid claims to price a limited-benefit capitation contract overstates the managed care organization's obligations when substantial services remain carved out.
Official syllabus reference: [1]
51. Part D Deductible, Initial, and Catastrophic Phases
Following the redesign effective in 2025, standard Part D has deductible, initial-coverage, and catastrophic phases; the former coverage-gap phase is absent. Beneficiaries generally pay deductible costs, then initial-phase cost sharing, with no beneficiary cost sharing in catastrophic coverage. For applicable brands with full discounts, initial shares are 25% beneficiary, 65% plan, and 10% manufacturer; catastrophic shares are 60% plan, 20% manufacturer, and 20% federal reinsurance. Generic allocations differ. Phase limits change by year, and low-income subsidies or manufacturer exceptions require separate treatment. Split boundary-crossing claims before applying shares.
Worked example: Assume $400 of an applicable-brand claim falls in initial coverage and $100 in catastrophic coverage. The plan pays $260 plus $60, or $320. Beneficiary, manufacturer, and federal payments are $100, $60, and $20 respectively, reconciling to the $500 claim.
Common mistake: Using the former coverage-gap allocation for a redesigned benefit misstates payer liabilities, and applying one phase's shares across a boundary-crossing claim does likewise.
Official syllabus reference: [1]
52. Medicaid Capitation Development Under ASOP 49
Medicaid capitation development starts with data appropriate to the covered population and services, then adjusts for completion, trend, benefit changes, program changes, and relevant population differences. Add supported nonbenefit costs and other provisions consistently with the contract and applicable requirements. ASOP 49 addresses development and certification; a precise spreadsheet result does not by itself establish actuarial soundness. Reconcile rate cells, time periods, and carved-out services. Percentage-of-premium expenses require algebraic loading, while projection-date benefit costs should not receive another full historical trend adjustment.
Worked example: Completed claims are $300 PMPM after removing carved-out services. A 4% trend produces $312; adding a $10 projection-date benefit and $18 fixed expenses gives $340. With a 5% premium-based load, the indicated rate is $340 divided by 0.95, or $357.89.
Common mistake: Adding a five-percent premium load by multiplying costs by 1.05 understates the required premium because the stated percentage applies to final revenue.
Official syllabus reference: [1]
53. ACA Single-Risk-Pool Pricing and Selection Dynamics
Within applicable ACA individual and small-group rules, insurers develop pricing from a single risk pool for the relevant market and state, with permitted plan and rating adjustments. Pool composition matters because guaranteed availability and rating restrictions limit direct health-status pricing. If healthier members leave, average claims can rise even when no remaining member's expected cost changes. Premium increases can then affect enrollment further. Analyze this selection mechanism separately from medical trend, and avoid assuming that a mathematical illustration predicts an inevitable market outcome or permits otherwise prohibited rating factors.
Worked example: A pool contains 100 members costing $200 monthly and 100 costing $600, averaging $400. If 50 lower-cost members leave, average cost becomes $466.67 for the remaining 150. The increase reflects changed composition, not a rise in either subgroup's cost.
Common mistake: Explaining every premium increase through provider inflation overlooks how enrollment selection can change average claims without changing subgroup service costs.
Official syllabus reference: [1]
54. ACA Risk Adjustment Versus Claim Reimbursement
ACA risk adjustment redistributes funds among participating insurers within the applicable market framework based on relative risk and prescribed transfer calculations. It aims to reduce incentives to select healthier risks, but it does not reimburse each insurer for its actual claims or guarantee profitability. Financial projections should estimate both claim costs and transfers consistently with enrollment, benefits, and the model. Diagnosis capture, relative market risk, and transfer settlement timing can affect results. Distinguish this mechanism from premium subsidies, reinsurance, and medical loss ratio rebates, which have different recipients and purposes.
Worked example: A plan expects $40 million claims and a $2 million risk-adjustment receipt. Netting the transfer produces $38 million before other items, but an unexpected $5 million claim increase does not automatically produce another $5 million receipt. Relative modeled risk, not actual losses alone, governs transfers.
Common mistake: Treating risk adjustment as dollar-for-dollar protection against adverse claims confuses a relative-risk transfer mechanism with reimbursement or stop-loss insurance.
Official syllabus reference: [1]
Flow of Funds
55. Sources, Intermediaries, and Final Uses
A flow-of-funds framework separates original financing sources from intermediary transfers and final uses. Households, employers, and governments provide funds; insurers or public programs pool and administer them; providers receive payment for services. Premiums and the claims they finance are different stages of the same money's path. Direct cost sharing reaches providers through a separate route. Choose whether the analysis measures financing, payer expenditure, or provider receipts, and reconcile consistently. Counting every transfer as additional health spending inflates totals and obscures who ultimately bears the cost.
Worked example: Employers and workers pay $10 million premiums, of which the insurer pays $8 million to providers and retains $2 million for administration and margin. Adding premiums and provider payments gives $18 million, but original funding remains $10 million before any separate household cost sharing.
Common mistake: Adding premium revenue to the insurer's claim payments as final spending counts the same financing twice as it moves through an intermediary.
Official syllabus reference: [1]
56. Physician Referrals and Downstream Spending
Physicians influence spending through diagnosis, treatment choices, referrals, prescriptions, and site-of-care decisions, beyond the amount paid for their own visits. Payment incentives, clinical evidence, patient needs, network design, and ownership relationships can shape these decisions. Measure both professional fees and downstream resource use when evaluating physician-related spending. Lower visit prices need not lower total cost if referrals shift toward higher-priced settings or greater service intensity. Conversely, increased primary care spending may support lower downstream costs, but that relationship requires evidence rather than an automatic savings assumption.
Worked example: A network reduces office visit payments by $20 for 1,000 visits, saving $20,000. If associated imaging shifts to a setting costing an additional $200 for 150 studies, downstream spending rises $30,000. Total spending increases $10,000 despite lower professional fees.
Common mistake: Evaluating physician economics only through office fee schedules overlooks referral patterns and site-of-care choices that can dominate downstream spending.
Official syllabus reference: [1]
57. Hospital Bargaining Power and Network Substitutability
Hospital negotiating power depends partly on how easily an insurer can offer an attractive, adequate network without that hospital or system. Unique services, geographic concentration, brand preference, physician alignment, and employer demand can reduce substitutability. Consolidation can strengthen bargaining leverage without changing the resource cost of each service, although effects vary by market. Analyze negotiated prices separately from utilization and case mix. A system can compete simultaneously for patients, physicians, and payer contracts, so a narrow comparison of posted charges does not establish its actual bargaining position.
Worked example: Two hospitals provide similar routine services, but one is the only local provider of a specialized pediatric service. An insurer may find excluding that system difficult, affecting negotiations across the contract. The resulting leverage need not reflect higher production costs for routine services.
Common mistake: Assuming negotiated hospital prices directly measure clinical resource costs ignores bargaining leverage, network dependence, and differences between charges and actual payments.
Official syllabus reference: [1]
58. Fee-for-Service, Capitation, and Bundled Payment
Fee-for-service links payment to individual services, capitation pays a defined amount per covered person for specified responsibilities, and bundled payment links payment to a defined episode or service package. Each reallocates volume, intensity, and utilization risk differently. Contract boundaries determine which providers bear costs and which services remain outside the arrangement. Capitation does not automatically transfer every medical risk, and a bundle requires clear episode definitions and outlier treatment. Evaluate incentives alongside quality measures and risk adjustment rather than assuming any payment method inherently guarantees lower cost or better care.
Worked example: Under fee-for-service, ten additional visits at $100 generate $1,000 more revenue. Under an otherwise fixed capitation contract covering those visits, revenue does not increase, while delivery costs may. A bundled surgical payment instead depends on the defined episode and included follow-up services.
Common mistake: Calling every fixed payment capitation overlooks episode-based bundles and ignores how contract scope determines the utilization risk actually transferred.
Official syllabus reference: [1]
59. Canadian Public Insurance and Mixed Delivery
Canadian health financing combines federal support, provincial and territorial administration, and public and private funding channels. Core publicly insured hospital and physician services should be distinguished from other services whose coverage varies by jurisdiction and population. Public financing does not imply uniform government ownership or employment of providers: physicians can practice independently while receiving public payments. Separate who raises funds, who administers coverage, and who delivers care. Avoid both double counting intergovernmental transfers and assuming that all health services fall within a single nationwide benefit package.
Worked example: A province uses tax revenues and federal transfers to pay hospitals and independent physician practices for insured services. A household separately pays for an uncovered service. The physician's public payment identifies the financing channel without establishing that the physician is employed by the provincial government.
Common mistake: Equating a publicly financed physician service with government employment confuses the payer's identity with the provider's ownership and organizational arrangement.
Official syllabus reference: [1]
60. Canada Health Transfer and Fiscal Sustainability
A federal health transfer supports provincial and territorial financing but does not itself purchase an additional service beyond the expenditure it helps fund. Fiscal sustainability depends on the relationship among health spending growth, tax-base growth, transfer growth, and other budget demands. A transfer's growth rate can differ from health expenditure growth, shifting the share funded from provincial own-source revenue. The syllabus's historical analysis of the 2014 transfer revision should be interpreted in its historical setting; it does not establish every transfer rule or policy parameter applicable in 2026.
Worked example: A province spends C$10 billion, including C$2 billion financed by a transfer. Next year spending grows 5% to C$10.5 billion while the transfer grows 3% to C$2.06 billion. Required own-source funding rises from C$8 billion to C$8.44 billion, or 5.5%.
Common mistake: Assuming equal percentage growth in transfers and spending preserves fiscal balance ignores their different starting amounts and the province's remaining funding obligation.
Official syllabus reference: [1]